Contributions to medical research and literature
Academic contributions to medical science
Research on cardiac markers in organophosphate poisoning prognosis, studying the relationship between QT interval changes and patient outcomes in organophosphate poisoning cases.
Study on the effectiveness of sulfonylurea class drugs in diabetes management, evaluating their role in glycemic control and long-term outcomes in Type 2 Diabetes Mellitus patients.
Sharing knowledge and expertise at medical conferences
Invited as Guest Speaker for medical conferences conducted by Novartis, sharing insights on cardiovascular and diabetes management.
Guest speaker at AstraZeneca medical conferences, discussing latest advancements in cardio-diabetes care.
Invited speaker at Abbott medical symposia, presenting on comprehensive diabetes management strategies.
Participated as a speaker for a USV-initiated medical program on Facebook Live, reaching a wider audience with diabetes education.
Participation in observational studies and clinical research
Participated in observational studies conducted by Biocon, contributing to research on diabetes management and treatment outcomes.
Active participation in clinical studies conducted by Glenmark Pharmaceuticals, contributing to evidence-based medicine.
Contributing to real-world evidence generation through participation in various observational studies in diabetes and cardiovascular medicine.